Other Clinical Trial - Registry of Pancreatic Exocrine Insufficiency.

Status Recruiting

Clinical Trial Summary

A prospective, cross-sectional, observational study has been designed with the aim of the study is to evaluate the diagnosis and management of patients with pancreatic exocrine insufficiency secondary to different pancreatic diseases and conditions in clinical practice. A registry has been develop to include patients older than 18 years diagnosed with pancreatic exocrine insufficiency, sho are willing to participate in the study and sign the informed consent. Registry includes demographics, toxic habits,pharmacological therapies, underlying disease that causes pancreatic exocrine insufficiency.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Exocrine Pancreatic Insufficiency

Clinical Trial Details

NCT number	NCT05450627
Study type	Observational [Patient Registry]
Source	Hospital Clinico Universitario de Santiago
Contact	J. Enrique Dominguez-Munoz, Prof, MD, PhD
Phone	-34 981 951 364
Email	juan.enrique.dominguez.munoz@sergas.es
Status	Recruiting
Phase
Start date	June 1, 2021
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02823964` - EASY: Extended Access to Sollpura Over Years	Phase 4
Completed	`NCT02563080` - Pancreatic Exocrine Insufficiency in Acute Pancreatitis
Completed	`NCT01427725` - Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency
Completed	`NCT01430234` - Enzyme Suppletion in Exocrine Pancreatic Dysfunction	Phase 4
Completed	`NCT05082051` - Oral CDX-7108 in Healthy Adults and EPI Subjects	Phase 1
Completed	`NCT03236038` - Prevalence of Exocrine Pancreatic Insufficiency in Patients With Decompensated Cirrhosis
Completed	`NCT03407534` - Detection of Exocrine Pancreatic Insufficiency in Patients With Diarrhea and Bloating
Completed	`NCT02598128` - Safety, Tolerability and Fat Absorption Using Enteral Feeding In-line Enzyme Cartridge (Relizorb)	N/A
Completed	`NCT00559364` - Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea	Phase 3
Completed	`NCT00408317` - Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)	Phase 3
Recruiting	`NCT04548778` - BÜHLMANN fPELA in the Diagnosis of Exocrine Pancreatic Insufficiency
Completed	`NCT00449878` - Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency	Phase 3
Completed	`NCT00981214` - Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency	Phase 3
Completed	`NCT00297167` - Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency	Phase 3
Recruiting	`NCT05480241` - Exocrine Pancreatic Insufficiency After Acute Pancreatitis and Pancreatic Enzyme Replacement Therapy	N/A
Recruiting	`NCT05261997` - Endotherapy for Painless Chronic Pancreatitis	N/A
Completed	`NCT02370537` - A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI	Phase 2
Completed	`NCT00559052` - An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI)	Phase 2
Recruiting	`NCT04112836` - Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer
Completed	`NCT06278272` - AI Evaluation of Pancreatic Exocrine Insufficiency in CP Patients